Page 457 - Clinical Hematology_ Theory _ Procedures ( PDFDrive )
P. 457

CHAPTER 22  ■  Lymphoid and Plasma Cell Neoplasms                                  441




                   Clinical Signs and Symptoms                                                                                      Ch  r  cteristic  lly,  bloo    s    ples    re    escribe      s  h  v-

                                                                                                                               ing  hyperviscosity.  Detecting    onoclon  l  g      op  thies
                   T e sy  pto  s o  WM   re   ue to the extent o  tu  or inf l-                                               usu  lly involves seru   protein electrophoresis (SPEP)   n

                   tr  tion   n   to elev  te   IgM levels in the bloo   circul  tion.                                         i    unoelectrophoresis (IEP) to test both seru     n   urine.

                   Sy  pto  s inclu  e we  kness,    tigue   ttribut  ble to   ne  i  ,                                        A    ition  lly,  cryoglobulins c  n be   etecte   in the p  tient’s

                     n   blee  ing. Bone p  in is virtu  lly nonexistent. About one                                            seru  .  Cryoglobulins    re  proteins  th  t  precipit  te  or  gel

                    ourth o  p  tients with WM h  ve neurologic  l   bnor    lities.                                           when coole   to 0°C   n     issolve when he  te  . In   ost c  ses,

                   T e inci  ence o  in ection is twice the nor    l r  te. P  tients                                            onoclon  l cryoglobulins   re IgM or IgG.

                   usu  lly su  er  ro   chronic   ne  i     n   blee  ing episo  es.

                   T ro  bocytopeni     n   hyperviscosity     y   lso contribute                                              Treatment and Prognosis

                   to the blee  ing   isor  er.

                                                                                                                               T er  py is postpone    or   sy  pto    tic p  tients,   n   pro-

                   Laboratory Data                                                                                             gressive   ne  i   is the   ost co    on in  ic  tion  or initi  tion

                                                                                                                               o   tre  t  ent.  M  in  ther  peutic  options  inclu  e    lkyl  ting
                   T e   ost consistent  e  ture o  the bone     rrow or ly  ph                                                 gents, nucleosi  e   n  logues,   n   rituxi    b. Novel  gents,

                   no  es  o   WM  p  tients  is  the  presence  o   pleo  orphic                                               or ex    ple, vortezo  ib, show pro  ise   s    t  rgete   ther  py

                   B-line  ge cells   t   i  erent st  ges o      tur  tion, such   s s    ll                                  option in WM.

                   ly  phocytes,  ly  phopl  s    cytoi    cells  (  bun    nt  b  so-                                              Prognostic     ctors  inclu  e  the  p  tient’s    ge,  β -
                                                                                                                                                                                                                                 2
                   philic  cytopl  s    but ly  phocyte-like nuclei),    n   pl  s                                               icroglobulin level,   onoclon  l protein level, he  oglobin

                   cells. Bone     rrow     st cells o  WM p  tients overexpress                                               concentr  tion,   n   pl  telet count. T e reporte     e  i  n sur-

                   the CD40 lig  n   (CD154), which is    potent in  ucer o  B-cell                                            viv  l o  p  tients with WM r  nges between 5   n   10 ye  rs

                   exp  nsion. T e ly  phocyte–pl  s     cells v  ry   orphologi-                                               ro   the ti  e o    i  gnosis.

                   c  lly,  r  nging   ro    s    ll  ly  phocytes  to  obvious  pl  s

                   cells (Fig. 22.21). T eir cytopl  s   is  requently r  gge     n

                       y  cont  in  perio  ic    ci  -Schi    (PAS)-positive      teri  l                                        NOTE: This is a good time to complete end of the chapter

                   th  t is prob  bly i  entic  l to the circul  ting     croglobulin.                                           Review Questions.

                        T e tot  l leukocyte count is usu  lly nor    l, with   n   bso-

                   lute ly  phocytosis. Mo  er  te to severe   egrees o    ne  i

                    re  requently observe   on peripher  l bloo   s  e rs   s well                                             CHAPTER HIGHLIGHTS

                     s roule  ux  or    tion. T e p  tient’s pl  s     volu  e     y be

                   gre  tly incre  se  ,   n   the ESR is incre  se  . Pl  telet counts                                        Leukemias and Lymphomas

                     re  usu  lly  nor    l.  Blee  ing  c  use    by    bnor    lities  in

                   pl  telet      hesiveness   n   prothro  bin ti  e      y be  seen,                                         ■   T e ter   ly  phoproli er  tive   isor  er inclu  es the v  ri-

                     n   the v  lues o     ctor VIII     y be low.                                                                  ous  or  s o  leuke  i  s   n   ly  pho    s th  t   re o  ly  -
                                                                                                                                    phoreticul  r origin.

                                                                                                                               ■   Ly  phoi   neopl  s   cl  ssif c  tions   re b  se   on the   is-

                                                                                                                                    tribution o    ise  se   s leuke  i   or ly  pho    . During the

                                                                                                                                    progression o    ise  se in so  e ly  pho    s, the     lign  nt

                                                                                                                                    cells     y spill into the bloo   circul  tion. T is spillover

                                                                                                                                        y pro  uce    leuke  ic ph  se o  the   ise  se.

                                                                                                                               ■     r  nsitions to    leuke  ic ph  se   re r  re in   isor  ers such

                                                                                                                                      s Ho  gkin   ise  se but   re not unco    on in the well-

                                                                                                                                      i  erenti  te   non-Ho  gkin ly  phocytic ly  pho    s.



                                                                                                                               Chronic Lymphocytosis



                                                                                                                               ■   Te WHO Cl  ssif c  tion o    u  ours o  the H  e    topoietic

                                                                                                                                     n   Ly  phoi     issues h  s enh  nce   the cl  ssif c  tion o

                                                                                                                                    ly  phoi   neopl  s  s by inclu  ing i    unophenotypic  e  -

                                                                                                                                    tures   n   genetic   bnor    lities to   ef ne   i  erent   isor  ers.

                                                                                                                               ■   Ex    ples  o     isor  ers  o   the      ture  B-cell  neopl  s

                                                                                                                                    cl  ssif c  tion  inclu  e  CLL/SLL,  B-PLL,    n    h  iry  cell

                                                                                                                                    leuke  i  .




                   FIGURE  22.21  W  l  enströ  .  Bone      rrow    spir  te  showing                                         Chronic Lymphocyte Leukemia/ Small
                      lign  nt  cells  with  ly  phoi      n    pl  s   cytoi     orphology.                                   Lymphocytic Lymphoma

                   (Reprinte    ro   Greer JP, et   l. Wintrobe’s Clinical Hematology,

                   11th e  , Phil    elphi  , PA: Lippincott Willi    s & Wilkins, 2004,                                       ■   Chronic leuke  i  s   re gener  lly ch  r  cterize   by the

                   with per  ission.)                                                                                               presence o  leukocytosis with   n incre  se   nu  ber o
   452   453   454   455   456   457   458   459   460   461   462